Taysha Gene Therapies, Inc. reported a net loss of $109.0M in fiscal year 2025. This represents a decrease of 22.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Taysha Gene Therapies, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TSHA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TSHA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Taysha Gene Therapies, Inc. financials
Frequently Asked Questions
What was Taysha Gene Therapies, Inc.'s net income in fiscal year 2025?
Taysha Gene Therapies, Inc. reported a net loss of $109.0M in fiscal year 2025.
How fast is Taysha Gene Therapies, Inc.'s net income growing?
Taysha Gene Therapies, Inc. (TSHA) net income fell by 22.1% year over year, from -$89.3M to -$109.0M in fiscal year 2025.
How has Taysha Gene Therapies, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Taysha Gene Therapies, Inc. (TSHA) net income went from -$60.0M in fiscal year 2020 to -$109.0M in fiscal year 2025.
What was Taysha Gene Therapies, Inc.'s net income in the most recent quarter?
Taysha Gene Therapies, Inc. (TSHA) reported -$46.6M in net income in Q2 2026. This represents a decrease of 73.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Taysha Gene Therapies, Inc. (TSHA) reported on that line in every period on record.